IL-17 is produced under particular conditions such as environmental stimuli (pathogens or skin trauma) or due to exposure to keratinocyte autoantigens (such as LL37 cathelicidin or nucleic acid complexes), and its signals produce an inflammatory response of the feed forward type in keratinocytes, which further accelerates the development of psoriasis [6,7]. Here, IL17A is linked to psoriasis.